Apple launched ResearchKit, its iOS-based platform for clinical research, in March with an initial class of five trials focused on a range of health conditions.  Nearly seven months later, the tech giant is welcoming three new trials focused on epilepsy, autism, and melanoma.  “ResearchKit was designed to upend how medical research is done.” (Forbes)